L01FF02 - pembrolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
J05AP54 - elbasvir and grazoprevir : Belongs to the class of antivirals for treatment of HCV infections. Used in the treatment of hepatitis C viral infections.
J01DI54 - ceftolozane and beta-lactamase inhibitor : Belongs to the class of other cephalosporins and penems. Used in the systemic treatment of infections.
L01FF02 - pembrolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
J05AP54 - elbasvir and grazoprevir : Belongs to the class of antivirals for treatment of HCV infections. Used in the treatment of hepatitis C viral infections.
L01FF02 - pembrolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.
J05AP54 - elbasvir and grazoprevir : Belongs to the class of antivirals for treatment of HCV infections. Used in the treatment of hepatitis C viral infections.
J01DI54 - ceftolozane and beta-lactamase inhibitor : Belongs to the class of other cephalosporins and penems. Used in the systemic treatment of infections.